← Human Trials & Peer-Reviewed Studies
Vitamin D and asthma occurrence in children: A systematic review and meta-analysis.
Plain-language guide to PMID 34366195 (2022): meta-analysis of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).
Key Facts
- PMID
- 34366195
- Journal
- Journal of pediatric nursing
- Year
- 2022
- Study type
- Meta-Analysis
- Authors
- Wang Q et al. (4 authors)
- DOI
- 10.1016/j.pedn.2021.07.005
What This Paper Covers, in Plain Language
What It Covers
Researchers studied Vitamin D, K2, Magnesium and Zinc and Copper (Supplement) in this meta-analysis publication.
The association between serum 25-Hydroxyvitamin D (25-OHD) level and asthma occurrence in children was controversial.
The Pubmed, Ovid Medline, Embase, Cochrane Library were systematically searched up to April 13th 2020.
Who the Included Studies Covered
The age groups tagged for this paper are children.
All the study measured the serum 25-OHD level in children, or classified the children based on the 25-OHD level into severe vitamin D deficiency, insufficient deficiency and comparing the prevalence of asthma in childhood were included in their study.
Among them, 24 studies were included for analyzing the association between 25-OHD level and asthma, and 12 studies evaluated the treatment effect of vitamin D.
How the Review Was Done
A total of 35 studies were included in their meta-analysis.
What Was Measured
The association between serum 25-Hydroxyvitamin D (25-OHD) level and asthma occurrence in children was controversial.
The subject headings attached to it are Asthma, Dietary Supplements, Vitamin D and Vitamin D Deficiency.
The authors tagged it with the keywords 25-OHD, Children and Vitamin D supplement.
What This Means in Plain Language
This is a meta-analysis of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2022 (Journal of pediatric nursing), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Copper (Supplement) compound page, all human trials.
Our Notes on the Compounds
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.